No AI summary available for this article.
Why It Matters
Scarce data and tumor heterogeneity limit patient-level cancer treatment-response prediction.
Provenance
Discovered via ArXiv and published by ArXiv.
Key Claims
Original description
Scarce data and tumor heterogeneity limit patient-level cancer treatment-response prediction. Existing approaches predict response from pretreatment molecular profiles and drug representations, without explicitly modeling the molecular changes expected under treatment. We propose PerturbRx, a treatment-conditioned representation learning framework that learns intervention-induced latent transitions and uses them as patient-drug response features. PerturbRx trains a drug- and dose-conditioned transition predictor from context-matched but cell-unpaired control and treated single-cell populations...
Discovered via ArXiv
Research papers and preprints from arXiv.
Publisher: arxiv.org
ID: http://arxiv.org/abs/2608.21349v1 · Indexed 22 days ago